Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SI-BONE, Inc. Director's Dealing 2019

Aug 27, 2019

32647_dirs_2019-08-27_29d57261-d736-43b8-ae2d-6657f17cdd2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2019-08-26

Reporting Person: Freund John Gordon (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-08-26 Common Stock S 152424.00 $18.4038 Disposed 3819985.00 Indirect

Footnotes

F1: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.40 to $19.21, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein.